122 related articles for article (PubMed ID: 7018162)
21. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.
Lorenzi T; Marzioni D; Giannubilo S; Quaranta A; Crescimanno C; De Luca A; Baldi A; Todros T; Tranquilli AL; Castellucci M
Placenta; 2009 Jan; 30(1):35-40. PubMed ID: 19056122
[TBL] [Abstract][Full Text] [Related]
22. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
23. [Case study of the month. Pregnancy toxemia, with special reference to a case of intrauterine growth retardation].
Kango Tenbo; 1978 Feb; 3(2):127-33. PubMed ID: 246125
[No Abstract] [Full Text] [Related]
24. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth.
Chard T
Growth Regul; 1994 Sep; 4(3):91-100. PubMed ID: 7532055
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of intrauterine growth retardation.
Tejani NA
Obstet Gynecol; 1982 Mar; 59(3):329-31. PubMed ID: 7078879
[No Abstract] [Full Text] [Related]
26. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies.
Jeschke U; Schiessl B; Mylonas I; Kunze S; Kuhn C; Schulze S; Friese K; Mayr D
Int J Gynecol Pathol; 2006 Oct; 25(4):354-60. PubMed ID: 16990712
[TBL] [Abstract][Full Text] [Related]
27. Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births.
Abu-Amero SN; Ali Z; Bennett P; Vaughan JI; Moore GE
Mol Reprod Dev; 1998 Mar; 49(3):229-35. PubMed ID: 9491374
[TBL] [Abstract][Full Text] [Related]
28. Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia.
Nasiell J; Nisell H; Blanck A; Lunell NO; Faxén M
Acta Obstet Gynecol Scand; 1998 May; 77(5):492-6. PubMed ID: 9654168
[TBL] [Abstract][Full Text] [Related]
29. [Pre-eclampsia: a cause of fetal heart failure?].
Magny JF; Marrakchi Z; Dworzak P; Rougeot C; Dehan M; Gabilan JC
Arch Fr Pediatr; 1990 Apr; 47(4):283-5. PubMed ID: 2363617
[TBL] [Abstract][Full Text] [Related]
30. [Newborn infants born to toxemic mothers (toxemic fetopathy)].
Gómez-Gómez M; Cruz-Bolaños JA; Jiménez-Balderas EA; Tudón-Garcés H
Bol Med Hosp Infant Mex; 1985 Mar; 42(3):179-87. PubMed ID: 3986041
[No Abstract] [Full Text] [Related]
31. Placental IGF-I in severe intrauterine growth retardation.
Sorem KA; Siler-Khodr TM
J Matern Fetal Med; 1998; 7(1):1-7. PubMed ID: 9502661
[TBL] [Abstract][Full Text] [Related]
32. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction.
Langbein M; Strick R; Strissel PL; Vogt N; Parsch H; Beckmann MW; Schild RL
Mol Reprod Dev; 2008 Jan; 75(1):175-83. PubMed ID: 17546632
[TBL] [Abstract][Full Text] [Related]
33. [Conversion rate of (4-14C)dehydroepiandrosterone into ostrone and 17 beta-estradiol in normal as well as toxemic and diabetic placentas].
Lehmann WD
Acta Endocrinol Suppl (Copenh); 1971; 152():42. PubMed ID: 4251536
[No Abstract] [Full Text] [Related]
34. Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta?
Egbor M; Ansari T; Morris N; Green CJ; Sibbons PD
Placenta; 2006; 27(6-7):727-34. PubMed ID: 16125226
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction.
Jarvenpaa J; Vuoristo JT; Savolainen ER; Ukkola O; Vaskivuo T; Ryynanen M
Gynecol Endocrinol; 2007 Jun; 23(6):351-5. PubMed ID: 17616861
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies.
Knock GA; Sullivan MH; McCarthy A; Elder MG; Polak JM; Wharton J
J Pharmacol Exp Ther; 1994 Nov; 271(2):1007-15. PubMed ID: 7965763
[TBL] [Abstract][Full Text] [Related]
37. Gross pathology of the placenta in intrauterine growth retardation.
Bjøro K
Ann Chir Gynaecol; 1981; 70(6):316-22. PubMed ID: 7337404
[TBL] [Abstract][Full Text] [Related]
38. The placenta in pre-eclampsia and intrauterine growth restriction.
Roberts DJ; Post MD
J Clin Pathol; 2008 Dec; 61(12):1254-60. PubMed ID: 18641412
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key.
Ogawa M; Yanoma S; Nagashima Y; Okamoto N; Ishikawa H; Haruki A; Miyagi E; Takahashi T; Hirahara F; Miyagi Y
Placenta; 2007; 28(2-3):224-32. PubMed ID: 16580726
[TBL] [Abstract][Full Text] [Related]
40. Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta.
Bouhours-Nouet N; May-Panloup P; Coutant R; de Casson FB; Descamps P; Douay O; Reynier P; Ritz P; Malthièry Y; Simard G
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E171-7. PubMed ID: 15585597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
